Pyrocoll – 1 mg

Brand:
Cayman
CAS:
484-73-1
Storage:
-20
UN-No:
Non-Hazardous - /

Pyrocoll is a bacterial metabolite originally isolated from Streptomyces.{49000} It inhibits the growth of A. aurescens, A. globiformis, A. oxydans, A. pascens, and R. erythropolis bacteria (MICs = 10, 1, 10, 3, and 10 μg/ml, respectively) and HMO2, HepG2, and MCF-7 cancer cells (GI50s = 0.28, 0.42, and 2.2 μg/ml, respectively) in vitro. Pyrocoll is also active against P. falciparum and T. rhodesiense (IC50s = 1.19 and 1.97 μg/ml, respectively).  

 

Available on backorder

SKU: 26464 - 1 mg Category:

Description

A bacterial metabolite; inhibits the growth of A. aurescens, A. globiformis, A. oxydans, A. pascens, and R. erythropolis bacteria (MICs = 10, 1, 10, 3, and 10 μg/ml, respectively) and HMO2, HepG2, and MCF-7 cancer cells (GI50s = 0.28, 0.42, and 2.2 μg/ml, respectively); active against P. falciparum and T. rhodesiense (IC50s = 1.19 and 1.97 μg/ml, respectively)


Formal name: 5H,10H-dipyrrolo[1,2-a:1′,2′-d]pyrazine-5,10-dione

Synonyms: 

Molecular weight: 186.2

CAS: 484-73-1

Purity: ≥95%

Formulation: A solid


Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Research Area|Cancer||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Parasitic Diseases|African Sleeping Sickness||Research Area|Infectious Disease|Parasitic Diseases|Malaria